{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:13:13Z","timestamp":1780092793371,"version":"3.54.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>Despite the reduction in stent failure with newer-generation drug-eluting stents, very late stent thrombosis (VLST) remains an unpredictable and potentially catastrophic complication of coronary revascularization procedures and is associated with high morbidity and mortality. Here, we present an updated overview of the latest advances in understanding the causes of VLST. Clinical studies that revealed potential risk factors and pathophysiologic studies on the mechanisms of VLST are discussed. Importantly, novel insights from recent advances in intravascular imaging are included. To date, there is no clinical guideline for VLST treatment. We propose an evidence-based recommendation that an intravascular-imaging-informed percutaneous coronary intervention strategy combined with optimized antiplatelet therapy is the foundation for successful VLST clinical management. Moreover, the future of VLST prevention, such as improved patient risk stratification and advances in addressing late stent failure, are also discussed.<\/jats:p>","DOI":"10.1097\/crd.0000000000000283","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T14:42:59Z","timestamp":1570200179000},"page":"279-285","source":"Crossref","is-referenced-by-count":19,"title":["Very Late Stent Thrombosis in Drug-Eluting Stents New Observations and Clinical Implications"],"prefix":"10.1097","volume":"27","author":[{"given":"Xiang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Disease Center, First Hospital of Jilin University, Jilin University, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease Center, First Hospital of Jilin University, Jilin University, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Sun","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital and National Centre for Cardiovascular Diseases, Chinese academy of Medical Sciences & Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease Center, First Hospital of Jilin University, Jilin University, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease Center, First Hospital of Jilin University, Jilin University, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease Center, First Hospital of Jilin University, Jilin University, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease Center, First Hospital of Jilin University, Jilin University, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokang","family":"Qiao","sequence":"additional","affiliation":[{"name":"Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease Center, First Hospital of Jilin University, Jilin University, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230903","first-page":"e28","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association.","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig lecture ESC 2014.","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.","volume":"125","author":"R\u00e4ber","year":"2012","journal-title":"Circulation"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.","volume":"6","author":"Tada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2017.02.050","article-title":"Incident myocardial infarction and very late stent thrombosis in outpatients with stable coronary artery disease.","volume":"69","author":"Lemesle","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.109.903955","article-title":"Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART).","volume":"122","author":"Kimura","year":"2010","journal-title":"Circulation"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2014.04.022","article-title":"Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.","volume":"64","author":"Sarno","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jcin.2016.03.038","article-title":"Stent thrombosis with drug-eluting stents and bioresorbable scaffolds: evidence from a network meta-analysis of 147 trials.","volume":"9","author":"Kang","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"f6530","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.","volume":"347","author":"Navarese","year":"2013","journal-title":"BMJ"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"63","author":"Palmerini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.","volume":"10","author":"Capodanno","year":"2015","journal-title":"EuroIntervention"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry.","volume":"53","author":"van Werkum","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/heartjnl-2014-305743","article-title":"Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF.","volume":"101","author":"van Boven","year":"2015","journal-title":"Heart"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jcin.2012.07.012","article-title":"Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes.","volume":"5","author":"Dangas","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.amjcard.2013.07.002","article-title":"Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort.","volume":"112","author":"Jones","year":"2013","journal-title":"Am J Cardiol"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jcin.2014.04.017","article-title":"Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).","volume":"7","author":"Waksman","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4244\/EIJV9I8A157","article-title":"Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomography between subacute and late\/very late thrombosis in the Mechanism Of Stent Thrombosis (MOST) study.","volume":"9","author":"Parodi","year":"2013","journal-title":"EuroIntervention"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.jcin.2017.09.019","article-title":"Observational study of platelet reactivity in patients presenting with ST-segment elevation myocardial infarction due to coronary stent thrombosis undergoing primary percutaneous coronary intervention: results from the European prevention of stent thrombosis by an interdisciplinary global European effort registry.","volume":"10","author":"Godschalk","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/ATVBAHA.116.308763","article-title":"Newly formed reticulated platelets undermine pharmacokinetically short-lived antiplatelet therapies.","volume":"37","author":"Armstrong","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2011.04304.x","article-title":"Increased platelet turnover in patients with previous definite stent thrombosis.","volume":"9","author":"Grove","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R25-20230903","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1160\/TH16-10-0785","article-title":"Platelet turnover predicts outcome after coronary intervention.","volume":"117","author":"Freynhofer","year":"2017","journal-title":"Thromb Haemost"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/heartjnl-2014-306685","article-title":"The hypercoagulable profile of patients with stent thrombosis.","volume":"101","author":"Loeffen","year":"2015","journal-title":"Heart"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.115.019071","article-title":"Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography.","volume":"133","author":"Taniwaki","year":"2016","journal-title":"Circulation"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","article-title":"Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.","volume":"37","author":"Souteyrand","year":"2016","journal-title":"Eur Heart J"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCINTERVENTIONS.113.000797","article-title":"Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation.","volume":"7","author":"Im","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"R30-20230903","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcin.2011.09.018","article-title":"Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.","volume":"5","author":"Guagliumi","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R31-20230903","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","article-title":"Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment.","volume":"36","author":"Otsuka","year":"2015","journal-title":"Eur Heart J"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCINTERVENTIONS.113.000412","article-title":"Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment\u2013elevation myocardial infarction [corrected].","volume":"7","author":"Philip","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2011.05.076","article-title":"Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography.","volume":"162","author":"Li","year":"2013","journal-title":"Int J Cardiol"},{"key":"R34-20230903","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans.","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"R35-20230903","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehn553","article-title":"Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.","volume":"31","author":"Hassan","year":"2010","journal-title":"Eur Heart J"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2169\/internalmedicine.53.2177","article-title":"Causes of very late stent thrombosis investigated using optical coherence tomography.","volume":"53","author":"Amioka","year":"2014","journal-title":"Intern Med"},{"key":"R37-20230903","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/ehr384","article-title":"From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?","volume":"33","author":"Serruys","year":"2012","journal-title":"Eur Heart J"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"R39-20230903","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI.","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N Engl J Med"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/ccd.24938","article-title":"Late and very late coronary stent thrombosis: intravascular ultrasound findings and associations with antiplatelet therapy.","volume":"82","author":"Pesarini","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"R41-20230903","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.cjca.2013.04.001","article-title":"Late and very late stent thrombosis in patients with second-generation drug-eluting stents.","volume":"29","author":"Huang","year":"2013","journal-title":"Can J Cardiol"},{"key":"R42-20230903","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.jcin.2012.12.127","article-title":"Very late stent thrombosis 5 years after implantation of a sirolimus-eluting stent observed by angioscopy and optical coherence tomography.","volume":"6","author":"Ishihara","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R43-20230903","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"R44-20230903","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2010.05.066","article-title":"Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R45-20230903","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ncpcardio1397","article-title":"Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology.","volume":"6","author":"Davies","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"R46-20230903","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents.","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R47-20230903","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"key":"R48-20230903","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCULATIONAHA.109.854398","article-title":"Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.","volume":"120","author":"Cook","year":"2009","journal-title":"Circulation"},{"key":"R49-20230903","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.114.012658","article-title":"Hypersensitivity reaction in the US Food and Drug Administration-approved second-generation drug-eluting stents: histopathological assessment with ex vivo optical coherence tomography.","volume":"131","author":"Otsuka","year":"2015","journal-title":"Circulation"},{"key":"R50-20230903","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehv419","article-title":"Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium.","volume":"37","author":"Riegger","year":"2016","journal-title":"Eur Heart J"},{"key":"R51-20230903","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s10439-009-9719-9","article-title":"Hemodynamically driven stent strut design.","volume":"37","author":"Jim\u00e9nez","year":"2009","journal-title":"Ann Biomed Eng"},{"key":"R52-20230903","doi-asserted-by":"crossref","first-page":"e005386","DOI":"10.1161\/JAHA.116.005386","article-title":"Characteristics of earlier versus delayed presentation of very late drug-eluting stent thrombosis: an Optical Coherence Tomographic Study.","volume":"6","author":"Lee","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R53-20230903","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/euhj.2001.2707","article-title":"Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry.","volume":"23","author":"Uren","year":"2002","journal-title":"Eur Heart J"},{"key":"R54-20230903","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.acvd.2012.06.006","article-title":"Very late active stent thrombosis: contribution of optical coherence tomography.","volume":"107","author":"Souteyrand","year":"2014","journal-title":"Arch Cardiovasc Dis"},{"key":"R55-20230903","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.jacc.2012.09.071","article-title":"Neoatherosclerosis: the missing link between very late stent thrombosis and very late in-stent restenosis.","volume":"61","author":"Alfonso","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R56-20230903","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jcmg.2013.02.006","article-title":"OCT analysis in patients with very late stent thrombosis.","volume":"6","author":"Kang","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"R57-20230903","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4244\/EIJV10I12A251","article-title":"Very late stent thrombosis caused by neoatherosclerotic plaque rupture.","volume":"10","author":"Hougaard","year":"2015","journal-title":"EuroIntervention"},{"key":"R58-20230903","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.hlc.2013.04.120","article-title":"A rare mechanism of very late bare metal stent thrombosis\u2013role of optical coherence imaging in its evaluation and management.","volume":"23","author":"Subban","year":"2014","journal-title":"Heart Lung Circ"},{"key":"R59-20230903","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcmg.2017.11.015","article-title":"Clinical utility of combined optical coherence tomography and near-infrared spectroscopy for assessing the mechanism of very late stent thrombosis.","volume":"11","author":"Ino","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"R60-20230903","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrcardio.2015.32","article-title":"Causes, assessment, and treatment of stent thrombosis\u2013intravascular imaging insights.","volume":"12","author":"Ong","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"R61-20230903","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jcin.2009.01.012","article-title":"Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable\/unstable angina: insights from optical coherence tomography.","volume":"2","author":"Gonzalo","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R62-20230903","first-page":"128","article-title":"Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition.","volume":"3","author":"Tanigawa","year":"2007","journal-title":"EuroIntervention"},{"key":"R63-20230903","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/01.CIR.0000035239.90657.B1","article-title":"Background incidence of late malapposition after bare-metal stent implantation.","volume":"106","author":"Shah","year":"2002","journal-title":"Circulation"},{"key":"R64-20230903","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.113.000931","article-title":"Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition.","volume":"7","author":"Foin","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"R65-20230903","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","article-title":"Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).","volume":"136","author":"Adriaenssens","year":"2017","journal-title":"Circulation"},{"key":"R66-20230903","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.amjcard.2010.07.031","article-title":"Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis.","volume":"106","author":"Kang","year":"2010","journal-title":"Am J Cardiol"},{"key":"R67-20230903","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.coph.2012.07.015","article-title":"Optical coherence tomography: basics, current application and future potential.","volume":"12","author":"Abtahian","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"R68-20230903","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","article-title":"Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.","volume":"37","author":"Souteyrand","year":"2016","journal-title":"Eur Heart J"},{"key":"R69-20230903","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jacc.2017.09.014","article-title":"Mechanisms of very late bioresorbable scaffold thrombosis: the INVEST registry.","volume":"70","author":"Yamaji","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R70-20230903","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcin.2011.12.006","article-title":"New insights on stent thrombosis: in praise of large nationwide registries for rare cardiovascular events.","volume":"5","author":"Alfonso","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R71-20230903","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/clc.20648","article-title":"Long-term clinical outcomes after angiographically defined very late stent thrombosis of drug-eluting stent.","volume":"32","author":"Kim","year":"2009","journal-title":"Clin Cardiol"},{"key":"R72-20230903","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcin.2011.10.013","article-title":"Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis.","volume":"5","author":"Armstrong","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R73-20230903","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.hjc.2016.03.006","article-title":"Improved vascular healing after the successful treatment of very late sirolimus-eluting stent thrombosis with a bare metal stent implantation - A serial optical coherence tomography study.","volume":"57","author":"Bouki","year":"2016","journal-title":"Hellenic J Cardiol"},{"key":"R74-20230903","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.108.799403","article-title":"Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.","volume":"119","author":"van Werkum","year":"2009","journal-title":"Circulation"},{"key":"R75-20230903","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ahj.2009.12.032","article-title":"The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction.","volume":"159","author":"Ergelen","year":"2010","journal-title":"Am Heart J"},{"key":"R76-20230903","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2016.05.018","article-title":"Indications and outcomes of excimer laser coronary atherectomy: efficacy and safety for thrombotic lesions-the ULTRAMAN registry.","volume":"69","author":"Nishino","year":"2017","journal-title":"J Cardiol"},{"key":"R77-20230903","doi-asserted-by":"crossref","first-page":"e8328","DOI":"10.1097\/MD.0000000000008328","article-title":"Synergistic ELCA-aspiration-DES thrombus removal strategy-embolus impact in high-risk plaque: a case report.","volume":"96","author":"Imai","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R78-20230903","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/j.ijcard.2008.12.142","article-title":"A case of very late thrombosis of bare metal stent successfully treated with excimer laser coronary angioplasty.","volume":"145","author":"Larosa","year":"2010","journal-title":"Int J Cardiol"},{"key":"R79-20230903","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.amjcard.2014.03.041","article-title":"Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.","volume":"113","author":"Loh","year":"2014","journal-title":"Am J Cardiol"},{"key":"R80-20230903","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jjcc.2014.11.014","article-title":"Long-term outcomes following very late stent thrombosis of drug-eluting stent.","volume":"66","author":"Xu","year":"2015","journal-title":"J Cardiol"},{"key":"R81-20230903","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-9560-6-1","article-title":"Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy.","volume":"6","author":"Hobson","year":"2008","journal-title":"Thromb J"},{"key":"R82-20230903","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/ATVBAHA.115.306962","article-title":"Activation of peroxisome proliferator-activated receptor-\u03b4 as novel therapeutic strategy to prevent in-stent restenosis and stent thrombosis.","volume":"36","author":"Hyt\u00f6nen","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R83-20230903","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.jacc.2015.03.549","article-title":"Reducing in-stent restenosis: therapeutic manipulation of miRNA in vascular remodeling and inflammation.","volume":"65","author":"McDonald","year":"2015","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:17:53Z","timestamp":1693732673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000283","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}